Home » Topics » BioWorld Science, Infection

BioWorld Science, Infection
RSS

Chinese investigators divulge new recombinant fusion proteins

Sep. 16, 2021

Oragenics evaluates SARS-CoV-2 vaccine candidate in hamster challenge study

Sep. 16, 2021

Gilead Sciences patents new antiviral compounds

Sep. 16, 2021

U.S. researchers patent new compounds for malaria

Sep. 15, 2021

USAMRIID to test Navrogen's small-molecule NK cell activators against SARS-CoV-2 infection

Sep. 14, 2021

ARN-75039 or ARN-75041 as potent arenavirus fusion inhibitors

Sep. 14, 2021

Novel virulence factor LasB inhibitors for the treatment of P. aeruginosa infections

Sep. 10, 2021

Discovery of novel antibiotic class of tethered macrocyclic peptides

Sep. 10, 2021

New PIKfyve inhibitors identified at AcuraStem

Sep. 10, 2021

mRNA-1273 vaccine induces antibodies against SARS-CoV-2 variants

Sep. 9, 2021

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 2, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 30, 2026
CINP 2026: Gut microbiota could predict antidepressant response
BioWorld
The gut microbiota may be altered in people with depression as a result of treatment. These microorganisms reorganize differently in individuals who respond to...
Deep brain stimulation from the shallows: tomorrow’s BCI technology?
BioWorld
Deep brain stimulation (DBS) through implanted electrodes has enabled fundamentally new ways of treating certain disorders. More than 100,000 severely ill...
Ascending BCI systems deepen national security, ethical concerns
BioWorld
Ready or not, the future has arrived. Novel AI and brain-computer interface (BCI) systems are no longer confined to the realm of science fiction. As an...